Primer group for klebsiella pneumoniae and kit for detecting or identifying klebsiella pneumoniae
By designing a dual-fluorescence quantitative PCR method, which uses specific primers and probes to simultaneously amplify the LPTD and MERR genes of Klebsiella pneumoniae, the false negative problem in Klebsiella pneumoniae detection was solved, achieving high sensitivity and high specificity in detection, making it suitable for rapid and reliable clinical testing.
Patent Information
- Application Number
- CN202411109635.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-13
- Publication Date
- 2024-11-08
AI Technical Summary
Existing methods for detecting Klebsiella pneumoniae have false negative issues, and single-gene testing frequently results in missed detections, failing to meet the accuracy requirements of clinical testing.
Two sets of specific primer combinations (LPTD-F/LPTD-R and MERR-F/MERR-R) and probes (LPTD probe/MERR probe) were designed using dual quantitative PCR to simultaneously amplify the LPTD and MERR genes of Klebsiella pneumoniae. The Taqman probe dual quantitative PCR method was used to achieve detection in a single reaction.
It achieves a 100% detection rate for Klebsiella pneumoniae, avoids false negatives, and has high sensitivity and specificity. It is suitable for rapid and reliable clinical testing and is suitable for widespread application.
Smart Images

Figure CN118910296A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of microbial detection or identification, and relates to a primer set for Klebsiella pneumoniae and a kit for detecting or identifying Klebsiella pneumoniae. Background Art
[0002] Klebsiella pneumoniae belongs to the family Enterobacteriaceae and the genus Klebsiella, and is an aerobic Gram-negative bacillus. Klebsiella pneumoniae is a common opportunistic pathogen, with a detection rate of 1%-6% in the oropharynx of normal people and up to 20% in hospitalized patients. It often infects patients with underlying diseases, including alcoholics, diabetics, or chronic obstructive pulmonary disease, and can cause extraintestinal infections, including urinary tract infections, pneumonia, liver abscesses, endogenous endophthalmitis, surgical wound infections, and life-threatening infections, such as infective endocarditis and sepsis. Accurate and rapid detection of whether a patient is infected with Klebsiella pneumoniae is of great significance for clinical diagnosis and treatment and medication.
[0003] In pathogen detection, PCR is gradually replacing bacterial culture and serological methods due to its rapid and simple characteristics. The specificity of primers and probes is the basis of the specificity and sensitivity of PCR. Currently, many commercially available kits only have one pair of primers and one probe, and only detect one target gene of Klebsiella pneumoniae in one reaction. Due to the diversity of the Klebsiella pneumoniae genome, single-gene detection is bound to result in missed detections. Summary of the invention
[0004] In order to solve the above technical problems existing in the background technology, the present invention provides a primer set for Klebsiella pneumoniae with high detection accuracy and capable of meeting the technical requirements of relevant clinical detection, and a kit for detecting or identifying Klebsiella pneumoniae.
[0005] In order to achieve the above object, the present invention adopts the following technical solution:
[0006] A primer set for Klebsiella pneumoniae, characterized in that: the primer set for Klebsiella pneumoniae comprises two sets of dual fluorescence quantitative PCR primer combinations, and the sequence information of the primer set for Klebsiella pneumoniae is:
[0007] LPTD-F:gcagcaaaccagatgttggg;
[0008] LPTD-R:tcagaccgcgcaattcgata;
[0009] MERR-F: ctaacgctcgccacaatcaag;
[0010] MERR-R: aggactccagatcgggttca.
[0011] Preferably, the present invention also provides use of the primer set for Klebsiella pneumoniae as described above in detecting or identifying Klebsiella pneumoniae.
[0012] Preferably, LPTD-F and LPTD-R in the primer set for Klebsiella pneumoniae provided by the present invention are used to amplify the LPTD gene of Klebsiella pneumoniae; MERR-F and MERR-R in the primer set for Klebsiella pneumoniae are used to amplify the MERR gene of Klebsiella pneumoniae.
[0013] Preferably, the present invention further provides a probe for Klebsiella pneumoniae, characterized in that: the probe for Klebsiella pneumoniae comprises an LPTD probe and a MERR probe;
[0014] The sequence of the LPTD probe is: ctgctgctacgccatccgtcttgg;
[0015] The sequence of the MERR probe is: ctgtcgctgcccgagctgctg.
[0016] Preferably, the 5' end of the LPTD probe used in the present invention is labeled with a fluorescent reporter group 6-FAM, and the 3' end of the LPTD probe is labeled with a fluorescent quencher group BHQ1; the 5' end of the MERR probe is labeled with a fluorescent reporter group VIC, and the 3' end of the MERR probe is labeled with a fluorescent quencher group BHQ1.
[0017] Preferably, the present invention also provides use of the probe for Klebsiella pneumoniae in detecting or identifying Klebsiella pneumoniae.
[0018] Preferably, the LPTD probe provided by the present invention detects the LPTD gene of Klebsiella pneumoniae; and the MERR probe detects the MERR gene of Klebsiella pneumoniae.
[0019] Preferably, the present invention also provides a kit for detecting or identifying Klebsiella pneumoniae, characterized in that: the kit for detecting or identifying Klebsiella pneumoniae comprises a positive control, a negative control, a Probe qPCR MixMultiPlus mixed solution, ultrapure water, a primer set for Klebsiella pneumoniae as described above, and a probe for Klebsiella pneumoniae as described above; the positive control is a standard plasmid pMD18-T-LPTD and pMD18-T-MERR; and the negative control is ultrapure water.
[0020] Preferably, the present invention also provides a kit for detecting or identifying Klebsiella pneumoniae, and a method for detecting or identifying Klebsiella pneumoniae, characterized in that the method comprises the following steps:
[0021] 1) Obtain the sample to be tested;
[0022] 2) using the genomic DNA of the sample to be tested as a template, performing fluorescent quantitative PCR amplification using the kit for detecting or identifying Klebsiella pneumoniae as described above, and setting quality control at the same time;
[0023] 3) According to the amplification result of step 2), detecting or identifying whether the sample to be tested contains Klebsiella pneumoniae, and obtaining a detection or identification result.
[0024] Preferably, the reaction procedure of PCR amplification in step 2) adopted in the present invention is: pre-denaturation at 95°C for 20s, denaturation at 95°C for 1s, annealing at 65°C for 20s, and 40 cycles. At the end of the annealing step at 65°C, the fluorescence signal value is collected.
[0025] The total reaction volume of PCR amplification in step 2) is 25 μL, and the reaction system of PCR amplification is: ProbeqPCR Mix MuLtiPlus 12.5 μL, 10 μM LPTD-F 0.5 μL, 10 μM LPTD-R 0.5 μL, 10 μM LPTD probe 0.6 μL, 10 μM MERR-F 0.5 μL, 10 μM MERR-R 0.5 μL, 10 μM MERR probe 0.6 μL, DNA template 2 μL, ultrapure water 7.3 μL;
[0026] The quality control in step 2) is as follows: negative and positive controls should be set up for each experiment, where the negative control is ultrapure water and the positive control is a sample with a copy number of 3.38×10 6 copies / μL of pMD18-T-LPTD and the copy number is 1.41×10 6 An equal volume mixture of 1000 copies / μL of pMD18-T-MERR; the negative control has no Ct value or the Ct value is 0; the positive control Ct value is ≤25;
[0027] The detection or identification results in step 3) include positive samples to be tested, suspicious samples to be tested, negative samples to be tested, and doubts about the monitoring or identification results;
[0028] The determination condition for the positive of the sample to be tested is: in the dual-channel detection, any gene shows an S-type amplification curve, and the Ct value is ≤39;
[0029] The criteria for determining whether the sample to be tested is suspicious are: any gene has an S-type amplification curve, but the Ct value is greater than 39;
[0030] The condition for determining that the sample to be tested is negative is: no S-shaped amplification curve appears, or the curve exceeds the threshold but is not S-shaped;
[0031] If there is any doubt about the monitoring or identification results, the test or identification shall be repeated until the sample to be tested is positive, the sample to be tested is suspicious, or the sample to be tested is negative.
[0032] Beneficial effects of the present invention:
[0033] Based on the discovery of two highly conserved and specific genes (LPTD and MERR) in the Klebsiella pneumoniae genome, the present invention uses a single reaction to simultaneously detect two target genes of Klebsiella pneumoniae, thereby effectively solving the false negative problem of clinical detection of Klebsiella pneumoniae. Applications show that the detection rate of clinical isolates can reach 100%, meeting the technical requirements of relevant clinical detection. Specifically, the present invention has the following advantages:
[0034] 1) The Klebsiella pneumoniae LPTD gene and MERR gene selected by the present invention are both highly conservative and specific. The primers and probes designed based on the two genes in the present invention have high sensitivity and high specificity, and have no amplification reaction to human samples such as microorganisms (Streptococcus pneumoniae) that are prone to cause similar clinical symptoms, hemoglobin, and white blood cells that are potential interfering substances; the amplification has high specificity and good repeatability, and the detection rate of 320 randomly selected Klebsiella pneumoniae clinical isolates reaches 100%, with no missed detection.
[0035] 2) The kit for detecting or identifying two target genes of Klebsiella pneumoniae of the present invention has high specificity and high sensitivity, is suitable for rapid detection of Klebsiella pneumoniae, has high efficiency, reliability and simplicity, and is suitable for popularization and application.
[0036] 3) The present invention only requires one round of PCR amplification for the detection of Klebsiella pneumoniae, and the detection time is only 1 hour. Through the Taqman probe dual fluorescence quantitative PCR method, one tube reaction can simultaneously detect two highly conservative and specific target genes (LPTD protein gene and MERR protein gene) of Klebsiella pneumoniae, effectively solving the false positive and false negative problems of Klebsiella pneumoniae detection in the prior art. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] Figure 1 This is the amplification curve of two plasmid standards for the dual fluorescence quantitative PCR detection method for Klebsiella pneumoniae;
[0038] Figure 2 It is the standard curve of the dual fluorescence quantitative PCR detection method for Klebsiella pneumoniae;
[0039] Figure 3 It is the specific detection result of the dual fluorescence quantitative PCR detection method for Klebsiella pneumoniae;
[0040] Figure 4It is the detection limit result of the Klebsiella pneumoniae dual fluorescence quantitative PCR detection method for the standard plasmid;
[0041] Figure 5 This is the detection limit of Klebsiella pneumoniae dual fluorescence quantitative PCR detection method for Klebsiella pneumoniae culture. DETAILED DESCRIPTION
[0042] In order to make the purpose, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with specific embodiments.
[0043] Unless otherwise specified, the experimental methods used in the following examples are all conventional methods; the materials, reagents, etc. used can be obtained from commercial channels.
[0044] Example 1 Preparation of genomic DNA
[0045] After the bacteria in Table 1 were expanded and cultured using the standard culture method recorded by the strain collection institution, bacterial genomic DNA was extracted according to the instructions of the Kangwei Century Bacteria Genomic DNA Kit Bacterial Genomic DNA Extraction Kit (CW0552S). Finally, the obtained DNA product was adjusted to a concentration of 180ng / μL and stored in a -20℃ refrigerator.
[0046] The DNA / RNA of the viruses in Table 1 were extracted according to the instructions of the viral genome DNA / RNA rapid extraction kit (DP315-F) of Tiangen Biochemical Technology Co., Ltd., and then the TaKaRa PrimeScript TM II1st StrandcDNA Synthesis Kit Instructions: Reverse transcribe RNA into cDNA, and finally adjust the concentration of the obtained product to 180ng / μL and store it in a -20℃ refrigerator.
[0047] Table 1 Bacteria, viruses names and deposit numbers of various bacterial depositories
[0048]
[0049]
[0050] Example 2 Establishment of dual fluorescence quantitative PCR detection method for Klebsiella pneumoniae
[0051] Primers and probes were designed for the highly conservative and specific LPTD and MERR genes of Klebsiella pneumoniae. After repeated verification, primers and probes for specific detection of Klebsiella pneumoniae were screened out, as shown in Table 2. The fluorescence quantitative PCR detection system was finally determined through repeated exploration and optimization of the reaction program and reaction solution. The components of the reaction solution are shown in Table 3. The reaction program is pre-denaturation at 95℃ for 20s, denaturation at 95℃ for 1s, annealing at 65℃ for 20s, and 40 cycles of reaction. At the end of the annealing step at 65℃, the fluorescence signal value was collected.
[0052] Table 2 Primer and probe sequence list
[0053]
[0054]
[0055] Table 3 PCR system components
[0056]
[0057] Result interpretation:
[0058] Positive: In dual-channel detection, any gene shows an S-type amplification curve, and the Ct value is ≤39; Suspicious: Any gene shows an S-type amplification curve, but the Ct value is greater than 39; Negative: No S-type amplification curve appears, or the curve exceeds the threshold but is not S-shaped; For suspicious results, the experiment should be repeated. If the S-type amplification curve still appears after the repeated experiment, the negative control is not contaminated and it can be judged as positive.
[0059] Quality control: Negative and positive controls should be set up for each experiment. The negative control is ultrapure water, and the positive control is pMD-18T-LPTD positive standard plasmid (concentration of 3.38×10 6 copies / μL) and pMD-18T-MERR positive standard plasmid (concentration 1.41×10 6 The negative control has no Ct value or the Ct value is 0; the positive control Ct value is ≤25, otherwise the experimental result is invalid.
[0060] Example 3 Construction of standard plasmid and amplification standard curve
[0061] 3.1 Main instruments and reagents
[0062] The QPCR instrument was BIORAD CFX96, DNA polymerase 2xES TaqMasterMix (Dye) was purchased from Jiangsu Kangwei Century Biotechnology Co., Ltd., and pMD TM18-T Vector Cloning Kit (6011) and EASY Dilution (9160) were purchased from TaKaRa, plasmid DNA extraction kit (DP104) was purchased from Tiangen Biochemical Technology Co., Ltd., agarose gel DNA recovery kit (#36113) and DH5α competent cells were purchased from Shanghai Tolo Biotechnology Co., Ltd.
[0063] 3.2 Preparation of standard plasmid
[0064] The Klebsiella pneumoniae genomic DNA extracted in Example 1 was used as a template, and PCR amplification was performed with the upstream and downstream primers of the LPTD gene (LPTD-F and LPTD-R in Table 2) and the upstream and downstream primers of the MERR gene (MERR-F and MERR-R in Table 2). The target fragment sizes of the LPTD gene and the MERR gene were 157bp and 178bp. The amplification system was: 25 μL 2xESTaq MasterMix (Dye), 2 μL upstream primer (10 μM), 2 μL downstream primer (10 μM), 1 μL Klebsiella pneumoniae genomic DNA, and ddH2O was supplemented to 50 μL. The amplification procedure was: 94°C pre-denaturation for 2min, 94°C denaturation for 30s, 60°C annealing for 30s, 72°C extension for 30s, and 72°C final extension for 2min after 35 cycles. After the amplification product was identified by 1% agarose gel electrophoresis, an agarose gel DNA recovery kit was used to recover the target gene fragment.
[0065] The recovered target gene DNA fragment was referred to TaKaRa's pMD TM The instructions of 18-T Vector Cloning Kit were connected to the pMD18-T vector and transformed into DH5α competent cells. Positive clone colonies were selected for culture, and the plasmids were extracted using a plasmid extraction kit and then sequenced for verification. The ultra-micro spectrophotometer measured the absorbance of DNA at wavelengths of 230nm, 260nm, and 280nm to measure the purity and concentration of the plasmids. Finally, the concentrations of the LPTD gene and MERR gene recombinant plasmids were 165ng / μL and 182ng / μL, respectively. The plasmid copy number was calculated according to the following formula. The copy numbers of the LPTD gene and MERR gene recombinant plasmids were 5.28×10 10 copies / μL and 5.78×10 10 The standard plasmids that were successfully constructed were named pMD18-T-LPTD and pMD18-T-MERR. The standard plasmids pMD18-T-LPTD and pMD18-T-MERR were diluted 10-fold using EASYDilution to a final concentration of 5.28×10 0copies / μL and 5.78×10 0 copies / μL.
[0066] The calculation formula of plasmid copy number is as follows:
[0067]
[0068] 3.3 Establishment of amplification standard curve
[0069] The dilution factor was 10 1 ~10 8 1 μL of each of the pMD18-T-LPTD and pMD18-T-MERR standard plasmids was used as templates, that is, 2 μL of template was added to each reaction. Dual fluorescence quantitative PCR amplification was performed using the detection method established in Example 2. The results are shown in FIG. Figure 1 shown. Figure 1 The blue curves 1-8 are respectively 5.28×10 9 copies / μL~5.28×10 2 The amplification curves of the standard plasmid pMD18-T-LPTD with 5.78×10 copies / μL as template; yellow curves 1-8 are respectively 9 copies / μL~5.78×10 2 The amplification curve of the standard plasmid pMD18-T-MERR with 100 copies / μL as the template. The standard curve was established with the logarithmic value of the plasmid DNA copy number as the X-axis and the Ct value as the Y-axis. Figure 2 As shown, the blue curve is the standard curve of the LPTD gene, and the yellow curve is the standard curve of the MERR gene.
[0070] Figure 2 The standard amplification curve equation of Klebsiella pneumoniae LPTD gene is y = -3.289x + 43.778, and the correlation coefficient R 2 is 0.999, and the amplification efficiency is 101.4%; the standard amplification curve equation of the MERR gene is y=-3.317x+42.551, and the correlation coefficient R 2 The result showed that there was a good linear relationship between the logarithmic value of the copy number of the two plasmid standards and the Ct value, the primer and probe amplification efficiency was high, and the established dual real-time fluorescence quantitative PCR reaction system was stable.
[0071] Example 4 Analysis of specificity, sensitivity and repeatability of dual fluorescence quantitative PCR detection method for Klebsiella pneumoniae
[0072] 4.1 Specificity experiments
[0073] The genomic DNA prepared in Example 1 was used as a template, and 2 μL was added to each reaction. Ultrapure water was used as a negative control, and dual fluorescence quantitative PCR amplification was performed according to the primers and probes in the invention content and the detection method established in Example 2 to test the specificity of the method. Figure 3 It is the specific detection result of the dual fluorescence quantitative PCR method of the present invention (wherein: the blue curve is the amplification curve of the LPTD gene, the yellow curve is the amplification curve of the MERR gene, 1 is the amplification curve using the genomic DNA of Klebsiella pneumoniae as a template, 2-30 are the amplification curves using the genomic DNA of Streptococcus pneumoniae, Haemophilus influenzae, Bordetella pertussis, Staphylococcus aureus, Mycobacterium tuberculosis, Streptococcus pyogenes, Pseudomonas aeruginosa, Acinetobacter baumannii, Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus anginosus, Moraxella catarrhalis, Fusobacterium necroticum, Legionella pneumophila, Neisseria meningitidis, Stenotrophomonas maltophilia, Listeria monocytogenes, Streptococcus salivarius, Proteus mirabilis, Klebsiella oxytoca, Citrobacter freundii, influenza A virus, influenza B virus, parainfluenza virus, adenovirus, respiratory syncytial virus, rhinovirus, genomic DNA of Mycoplasma pneumoniae and ultrapure water as templates). In 40 cycles, only the reaction using Klebsiella pneumoniae genomic DNA as a template showed a positive amplification curve, and the other samples and negative control tests were all negative, indicating that the dual fluorescence quantitative PCR detection method established in the present invention has high specificity.
[0074] 4.2 Sensitivity analysis
[0075] 4.2.1 Standard plasmid detection limit experiment
[0076] The dilution factor was 10 1 ~10 10 1 μL of each of the pMD18-T-LPTD and pMD18-T-MERR standard plasmids was used as a template, that is, a total of 2 μL of template was added to each reaction. Dual fluorescence quantitative PCR amplification was performed according to the detection method established in Example 2.
[0077] The results are as follows Figure 4 The blue curves 1-10 are based on the concentrations of 5.28×10 9 copies / μL~5.28×10 0 The amplification curves of the standard plasmid pMD18-T-LPTD as a template, yellow curves 1-10 are based on the concentrations of 5.78×10 9 copies / μL~5.78×10 0 Amplification curve of the standard plasmid pMD18-T-MERR with copies / μL as template. Figure 4It can be seen that the detection limits of this method for the copy numbers of LPTD and MERR gene plasmid DNA of Klebsiella pneumoniae are 5.28×10 1 copies / μL and 5.78×10 1 copies / μL, indicating that the established dual fluorescence quantitative PCR detection method has a high detection sensitivity.
[0078] 4.2.2 Detection limit experiment of Klebsiella pneumoniae culture
[0079] The Klebsiella pneumoniae suspension was inoculated into a solid broth culture plate containing 5% sheep blood and cultured in a 37°C incubator for 18 to 24 hours. The plate was washed with physiological saline to collect the bacteria. The absorbance of the bacterial suspension at 37°C and 460 nm was adjusted to 0.5. The colony count result on the plate was 2.17×10 9 CFU / mL. The genomic DNA of 1 ml bacterial suspension was extracted using the Kangwei Century Bacteria Genomic DNA Kit (CW0552S), and then diluted 10 times in a gradient until the final concentration of genomic DNA corresponded to a bacterial concentration of 2.17×10 0 CFU / mL. The concentration was 2.17×10 7 CFU / mL~2.17×10 0 The bacterial genomic DNA (2 μL) corresponding to CFU / mL of Klebsiella pneumoniae was used as a template, and dual fluorescent quantitative PCR amplification was performed according to the detection method established in Example 2, with the lowest bacterial concentration that could be judged as positive as the detection limit.
[0080] like Figure 5 As shown, the blue curve is the amplification curve of the LPTD gene, the yellow curve is the amplification curve of the MERR gene, and 1-8 are 2.17×10 7 CFU / mL~2.17×10 0 The amplification curve of genomic DNA with CFU / mL as template. The detection limit of this method for Klebsiella pneumoniae culture was 2.17×10 2 CFU / mL (LPTD gene) and 2.17×10 2 CFU / mL (MERR gene), indicating that the established dual fluorescence quantitative PCR detection method has a high detection sensitivity and can meet the needs of clinical detection.
[0081] 4.3 Repeatability test
[0082] The dilution factor was 10 4 ~10 81 μL of pMD18-T-LPTD and pMD18-T-MERR standard plasmids were used as templates, i.e., 2 μL of templates were added to each reaction, and dual fluorescence quantitative PCR amplification was performed according to the detection method established in Example 2. Three replicates were set for each concentration gradient for repeated calculation within the group; the same method was used to perform three independent amplification experiments, and the differences between the groups were calculated. Coefficient of variation CV = (standard deviation SD / mean value Mean) × 100%.
[0083] The results are shown in Table 4. The amplification coefficients of LPTD and MERR genes ranged from 0.12% to 1.73% and 0.19% to 2.85%, respectively. The coefficients of variation of the amplification Ct values between groups in the two genomes were less than 3%, indicating that the method has good stability and repeatability.
[0084] Table 4 Repeatability test results
[0085]
[0086] Example 5 Detection of Klebsiella pneumoniae clinical isolates by dual fluorescence quantitative PCR detection method
[0087] The method described in Example 2 was used to culture 320 clinical isolates of Klebsiella pneumoniae collected from the clinic (1 mL of bacterial concentration was 1.58 × 10 4 The genomic DNA of Klebsiella pneumoniae liquid (CFU / ml) was extracted and amplified, and the total detection rate was 100%. Among them, there was 1 strain with negative LPTD gene detection, no MERR gene negative strain was found, and the number of LPTD gene and MERR gene double negative strains was 0. The results show that the method adopts double gene detection, which effectively avoids false negative results caused by the diversity of pathogen genomes.
[0088] Example 6 Clinical Detection Results of Dual Fluorescence Quantitative PCR Detection of Klebsiella Pneumoniae
[0089] Dual fluorescence quantitative PCR amplification was performed according to the detection method established in Example 2. Using a commercially available fluorescence quantitative PCR detection kit based on single gene detection as a reference, 2010 throat swab samples of patients with respiratory tract infection collected clinically were amplified and detected. The results are shown in Table 5. The positive rate of a single gene detection kit was 11.4% (230 / 2010), and that of the present invention was 12.1% (244 / 2010), and the coincidence rate of the two methods was 99.3% (1996 / 2010). Compared with the present method, the kit based on single gene detection had 14 missed detections.
[0090] Table 5 Clinical sample test results
[0091]
Claims
1. A primer set for Klebsiella pneumoniae, characterized in that: The primer set for Klebsiella pneumoniae includes two sets of dual fluorescence quantitative PCR primer combinations, and the sequence information of the primer set for Klebsiella pneumoniae is: LPTD-F: gcagcaaaccagatgttggg; LPTD-R:tcagaccgcgcaattcgata; MERR-F: ctaacgctcgccacaatcaag; MERR-R: aggactccagatcgggttca.
2. Use of the primer set for Klebsiella pneumoniae according to claim 1 in detecting or identifying Klebsiella pneumoniae.
3. The use according to claim 2, characterized in that: The LPTD-F and LPTD-R in the primer set for Klebsiella pneumoniae are used to amplify the LPTD gene of Klebsiella pneumoniae; the MERR-F and MERR-R in the primer set for Klebsiella pneumoniae are used to amplify the MERR gene of Klebsiella pneumoniae.
4. A probe for Klebsiella pneumoniae, characterized in that: The probe for Klebsiella pneumoniae includes an LPTD probe and a MERR probe; The sequence of the LPTD probe is: ctgctgctacgccatccgtcttgg; The sequence of the MERR probe is: ctgtcgctgcccgagctgctg.
5. The probe for Klebsiella pneumoniae according to claim 4, characterized in that: The 5' end of the LPTD probe is labeled with a fluorescent reporter group 6-FAM, and the 3' end of the LPTD probe is labeled with a fluorescent quencher group BHQ1; the 5' end of the MERR probe is labeled with a fluorescent reporter group VIC, and the 3' end of the MERR probe is labeled with a fluorescent quencher group BHQ1.
6. Use of the probe for Klebsiella pneumoniae according to claim 4 or 5 in detecting or identifying Klebsiella pneumoniae.
7. The use according to claim 6, characterized in that: The LPTD probe detects the LPTD gene of Klebsiella pneumoniae; and the MERR probe detects the MERR gene of Klebsiella pneumoniae.
8. A kit for detecting or identifying Klebsiella pneumoniae, characterized in that: The kit for detecting or identifying Klebsiella pneumoniae comprises a positive control, a negative control, a Probe qPCR Mix MultiPlus mixed solution, ultrapure water, a primer set for Klebsiella pneumoniae according to claim 1, and a probe for Klebsiella pneumoniae according to claim 4 or 5; the positive control is a standard plasmid pMD18-T-LPTD and pMD18-T-MERR; and the negative control is ultrapure water.
9. A method for detecting or identifying Klebsiella pneumoniae based on the kit for detecting or identifying Klebsiella pneumoniae according to claim 8, characterized in that: The method comprises the following steps: 1) Obtain the sample to be tested; 2) using the genomic DNA of the sample to be tested as a template, performing fluorescent quantitative PCR amplification using the kit for detecting or identifying Klebsiella pneumoniae as claimed in claim 8, and setting quality control at the same time; 3) According to the amplification result of step 2), whether Klebsiella pneumoniae exists in the sample to be tested is detected or identified to obtain the detection or identification result.
10. The method according to claim 9, characterized in that: The reaction procedure of PCR amplification in step 2) is: pre-denaturation at 95°C for 20s, denaturation at 95°C for 1s, annealing at 65°C for 20s, and 40 cycles. At the end of the annealing step at 65°C, the fluorescence signal value is collected. The total reaction volume of PCR amplification in step 2) is 25 μL, and the reaction system of PCR amplification is: Probe qPCRMix MultiPlus 12.5 μL, 10 μM LPTD-F 0.5 μL, 10 μM LPTD-R 0.5 μL, 10 μM LPTD probe 0.6 μL, 10 μM MERR-F 0.5 μL, 10 μM MERR-R 0.5 μL, 10 μM MERR probe 0.6 μL, DNA template 2 μL, ultrapure water 7.3 μL; The quality control in step 2) is as follows: negative and positive controls are set up for each experiment, where the negative control is ultrapure water and the positive control is a sample with a copy number of 3.38×10 6 copies / μL of pMD18-T-LPTD and the copy number is 1.41×10 6 An equal volume mixture of 1000 copies / μL of pMD18-T-MERR; the negative control has no Ct value or the Ct value is 0; the positive control Ct value is ≤25; The detection or identification results in step 3) include positive samples to be tested, suspicious samples to be tested, negative samples to be tested, and doubts about the monitoring or identification results; The determination condition for the positive of the sample to be tested is: in the dual-channel detection, any gene shows an S-type amplification curve, and the Ct value is ≤39; The criteria for determining whether the sample to be tested is suspicious are: any gene has an S-type amplification curve, but the Ct value is greater than 39; The condition for determining that the sample to be tested is negative is: no S-shaped amplification curve appears, or the curve exceeds the threshold but is not S-shaped; If there is any doubt about the monitoring or identification results, the test or identification shall be repeated until the sample to be tested is positive, the sample to be tested is suspicious, or the sample to be tested is negative.
